Filter
Custom request?
Show more
20 verified results
1g
Tirzepatide API | 1g
Produced in China | COA | GMP certified $ 406
2g
Tirzepatide API | 2g
Produced in China | COA | GMP certified $ 812
5g
Tirzepatide API | 5g
Produced in China | COA | GMP certified $ 2,030
Custom
Tirzepatide API | Custom
Produced in China | COA | GMP certified On Request
Producer CDMO Produced in Asia | Employees: 25+ | Audit Report: Currently Eurofins has no report for this supplier. Contact them to let them know you're interested! Certifications: CoA All certificates MSDS BSE/TSE ISO9001 CoA
Producer CDMO Produced in Asia | Audit Report: Currently Eurofins has no report for this supplier. Contact them to let them know you're interested! Certifications: CoA All certificates MSDS ISO9001 CoA
Take control of your API sourcing Submit a Special Inquiry and have Pharmaoffer activate verified suppliers.
Producer CDMO Produced in Asia | Employees: 10+ | Audit Report: Currently Eurofins has no report for this supplier. Contact them to let them know you're interested! Certifications: CoA All certificates MSDS BSE/TSE CoA
Producer Produced in Asia | Employees: 200 | Audit Report: Currently Eurofins has no report for this supplier. Contact them to let them know you're interested! Certifications: CoA All certificates MSDS BSE/TSE ISO9001 CoA
Producer Produced in Asia | Employees: 1500+ | Audit Report: Currently Eurofins has no report for this supplier. Contact them to let them know you're interested! Certifications: CoA | GMP All certificates GMP USDMF MSDS BSE/TSE CoA
Producer CDMO Produced in Asia | Employees: 50+ | Audit Report: Currently Eurofins has no report for this supplier. Contact them to let them know you're interested! Certifications: CoA | GMP See all 6 certificates All certificates GMP FDA USDMF ISO9001 CoA WC
Get full market intelligence report €399,- All Tirzepatide data. Full access. Full negotiation power
Producer Produced in Asia | Audit Report: Currently Eurofins has no report for this supplier. Contact them to let them know you're interested! Certifications: CoA All certificates CoA
Producer Produced in Asia | Employees: 250+ | Audit Report: Currently Eurofins has no report for this supplier. Contact them to let them know you're interested! Certifications: CoA | GMP All certificates GMP USDMF MSDS BSE/TSE CoA
Take control of your API sourcing
Producer CDMO Produced in Asia | Employees: 200 | Audit Report: Currently Eurofins has no report for this supplier. Contact them to let them know you're interested! Certifications: CoA All certificates MSDS BSE/TSE CoA
Distributor Produced in Europe | Employees: 50 | Audit Report: Currently Eurofins has no report for this supplier. Contact them to let them know you're interested! Certifications: CoA | GMP See all 6 certificates All certificates GMP USDMF MSDS ISO9001 KDMF CoA
Producer Produced in Asia | Employees: 1000+ | Audit Report: Currently Eurofins has no report for this supplier. Contact them to let them know you're interested! Certifications: CoA All certificates FDA USDMF MSDS BSE/TSE CoA
Distributor Produced in North America | Employees: 50+ | Audit Report: Currently Eurofins has no report for this supplier. Contact them to let them know you're interested! Certifications: CoA | GMP All certificates GMP MSDS BSE/TSE ISO9001 CoA
Producer Produced in Asia | Employees: 400+ | Audit Report: Currently Eurofins has no report for this supplier. Contact them to let them know you're interested! Certifications: CoA All certificates MSDS BSE/TSE CoA
Producer Produced in Asia | Employees: 60 | Audit Report: Currently Eurofins has no report for this supplier. Contact them to let them know you're interested! Certifications: CoA | CEP All certificates GMP CEP CoA
Producer Produced in Asia | Employees: 250+ | Audit Report: Currently Eurofins has no report for this supplier. Contact them to let them know you're interested! Certifications: CoA All certificates USDMF MSDS CoA
Producer Produced in North America | Audit Report: Currently Eurofins has no report for this supplier. Contact them to let them know you're interested! Certifications: CoA | GMP All certificates GMP MSDS CoA
Producer Produced in Asia | Audit Report: Currently Eurofins has no report for this supplier. Contact them to let them know you're interested! Certifications: CoA | GMP All certificates GMP MSDS BSE/TSE ISO9001 CoA
Producer Produced in Asia | Employees: 373 | Audit Report: Currently Eurofins has no report for this supplier. Contact them to let them know you're interested! Certifications: CoA | GMP All certificates GMP USDMF MSDS BSE/TSE CoA
Distributor Produced in Asia | Employees: 25 | Audit Report: Currently Eurofins has no report for this supplier. Contact them to let them know you're interested! Certifications: CoA | GMP See all 6 certificates All certificates GMP FDA MSDS BSE/TSE ISO9001 CoA
Trusted by 30,000+ registered pharma professionals: Reach multinationals, SMEs, compounding pharmacies & more!
A medication that supports glycemic control in adults with type 2 diabetes and assists chronic weight management in obese or overweight patients with related comorbid conditions.
Alimentary Tract and Metabolism Amino Acids, Peptides, and Proteins Blood Glucose Lowering Agents Drugs Used in Diabetes Gastrointestinal Hormones GLP-1 Agonists
Tirzepatide
biotech
2023788-19-2
DB15171
Approved drug, Investigational drug
A10BX16
Tirzepatide (CAS 2023788-19-2) is a 39‑amino‑acid synthetic peptide conjugated to a C20 fatty diacid designed to act as a dual agonist at the glucose‑dependent insulinotropic polypeptide and glucagon‑like peptide‑1 receptors. It is indicated as an adjunct to diet and physical activity for glycemic control in adults with type 2 diabetes and for chronic weight management in adults with obesity or overweight with at least one weight‑associated comorbidity. It has not been studied in patients with a history of pancreatitis and is not indicated for type 1 diabetes. In Europe, it may be used as monotherapy or in combination with other antidiabetic therapies. Approved products include Mounjaro for type 2 diabetes and Zepbound for weight management.
Tirzepatide lowers glucose by stimulating first‑ and second‑phase insulin secretion and suppressing glucagon release in a glucose‑dependent manner. It delays gastric emptying, decreases fasting and postprandial glucose, reduces food intake, and can improve insulin sensitivity. High albumin binding due to the fatty‑diacid conjugate contributes to a prolonged half‑life that supports once‑weekly administration.
The mechanism of action involves dual receptor agonism. GLP‑1 receptor activation enhances glucose‑stimulated insulin secretion, slows gastric transit, and reduces glucagon levels while influencing central pathways regulating satiety. GIP receptor activation also promotes glucose‑dependent insulin release, although the contribution of GIP receptor agonism to clinical glycemic and weight effects remains under investigation. Tirzepatide binds both receptors with high affinity, showing affinity comparable to native GIP at the GIP receptor and lower affinity than native GLP‑1 at the GLP‑1 receptor.
Tirzepatide is generally associated with gastrointestinal adverse effects typical of incretin‑based therapies, and caution is advised in individuals with risk factors for pancreatitis. Hypoglycemia risk increases when used with insulin or insulin secretagogues.
For API procurement, suppliers should demonstrate control of peptide sequence integrity, conjugation efficiency, stereochemical identity, and impurity profiles, supported by validated analytical methods and GMP‑aligned manufacturing documentation.
